Department of Internal Medicine, Carle Foundation Hospital, Urbana, Illinois, USA.
Department of Cardiology, Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, Pennsylvania, USA.
J Cardiovasc Electrophysiol. 2021 May;32(5):1411-1420. doi: 10.1111/jce.14986. Epub 2021 Mar 17.
The aim of this analysis was to evaluate the predictors associated with increased risk of permanent pacemaker implantation (PPMI) following transcatheter aortic valve replacement (TAVR).
While TAVR has evolved as the standard of care for patients with severe aortic stenosis, conduction abnormalities leading to the need for PPMI is one of the most common postprocedural complications.
A systematic literature search was performed to identify relevant trials from inception to May 2020. Summary effects were calculated using a DerSimonian and Laird random-effects model as odds ratio with 95% confidence intervals for all the clinical endpoints.
Thirty-seven observational studies with 71 455 patients were identified. The incidence of PPMI following TAVR was 22%. Risk was greater in men and increased with age. Patients with diabetes mellitus, presence of right bundle branch block, baseline atrioventricular conduction block, and left anterior fascicular block were noted to be at higher risk. Other significant predictors include the presence of high calcium volume in the area below the left coronary cusp and noncoronary cusp, use of self-expandable valve over balloon-expandable valve, depth of implant, valve size/annulus size, predilatation balloon valvuloplasty, and postimplant balloon dilation.
Fourteen factors were found to be associated with increased risk of PPMI after TAVR, suggesting early identification of high-risk populations and targeting modifiable risk factors may aid in reducing the need for this post TAVR PPMI.
本分析旨在评估经导管主动脉瓣置换术(TAVR)后永久性起搏器植入(PPMI)风险增加的相关预测因素。
虽然 TAVR 已成为严重主动脉瓣狭窄患者的标准治疗方法,但导致需要 PPMI 的传导异常是最常见的术后并发症之一。
进行了系统的文献检索,以确定从开始到 2020 年 5 月的相关试验。使用 DerSimonian 和 Laird 随机效应模型计算所有临床终点的汇总效应,以比值比和 95%置信区间表示。
确定了 37 项观察性研究,共 71455 例患者。TAVR 后 PPMI 的发生率为 22%。男性风险更高,且随年龄增长而增加。患有糖尿病、存在右束支传导阻滞、基线房室传导阻滞和左前束支阻滞的患者风险更高。其他重要的预测因素包括左冠状动脉瓣和非冠状动脉瓣下方区域钙含量高、使用自膨式瓣膜而非球囊扩张式瓣膜、植入深度、瓣膜大小/瓣环大小、预扩张球囊瓣膜成形术和植入后球囊扩张术。
发现 14 个因素与 TAVR 后 PPMI 风险增加相关,这表明早期识别高危人群并针对可改变的危险因素可能有助于减少 TAVR 后 PPMI 的需求。